TY - JOUR T1 - MicroRNAs 142-3p, miR-155 and miR-203 Are Deregulated in Gastric MALT Lymphomas Compared to Chronic Gastritis JF - Cancer Genomics - Proteomics JO - Cancer Genomics Proteomics SP - 75 LP - 82 VL - 14 IS - 1 AU - CONCEPCIÓN FERNÁNDEZ AU - BEATRIZ BELLOSILLO AU - MARIANA FERRARO AU - AGUSTÍN SEOANE AU - BLANCA SÁNCHEZ-GONZÁLEZ AU - SILVIA PAIRET AU - AINA PONS AU - LUIS BARRANCO AU - MARÍA CARMEN VELA AU - EVA GIMENO AU - LLUÍS COLOMO AU - CARLES BESSES AU - ALFONS NAVARRO AU - ANTONIO SALAR Y1 - 2017/01/01 UR - http://cgp.iiarjournals.org/content/14/1/75.abstract N2 - Background: Over the last years, our knowledge on pathogenesis of gastric MALT lymphoma has greatly improved, but its morphological diagnosis is still hampered by overlapping histological features with advanced chronic gastritis. MicroRNAs are deregulated in lymphomas, but their role and usefulness in gastric MALT lymphoma has not been extensively investigated. Materials and Methods: We analyzed the expression of 384 miRNAs using TaqMan microRNA assay in a training series of 10 gastric MALT lymphomas, 3 chronic gastritis and 2 reactive lymph nodes. Then, significantly deregulated miRNAs were individually assessed by real-time PCR in a validation series of 16 gastric MALT lymphomas and 12 chronic gastritis. Results: Gastric MALT lymphoma is characterized by a specific miRNA expression profile. Among the differentially expressed miRNAs, a significant overexpression of miR-142-3p and miR-155 and down-regulation of miR-203 was observed in gastric MALT lymphoma when compared to chronic gastritis. Conclusion: miR-142-3p, miR-155 and miR-203 expression levels might be helpful biomarkers for the differential diagnosis between gastric MALT lymphomas and chronic gastritis. ER -